Please Wait.....
Report
AI In Medical Imaging Market - Global Outlook & Forecast 2022-2027
Market Report I 2022-06-20 I 335 Pages I Arizton Advisory & Intelligence
The global AI in medical imaging market is expected to grow at a CAGR of 45.68% during the forecast period 2022-2027.
The constant increase in the number of diagnostic procedures and the decline in the number of radiologists, increasing work pressure on the radiologists, have increased the need for artificial intelligence adoption in the medical imaging space. The researchers are looking for multiple ways to implement artificial intelligence into medical imaging. The demand for artificial intelligence is constantly increasing in the medical imaging software market. From cardiac events, neurological conditions, fractures, or thoracic complications, artificial intelligence helps physicians to diagnose and provide treatment quickly. Implementing AI in medical imaging has enhanced medical screening, improved precision medicine software, reduced physicians' load, etc.
Technological Advancements Revolutionizing AI in Medical Imaging
- There have been many technological advancements in AI-based medical imaging technologies, which have shown their increasing acceptance in high-income countries. Some of the improvements include the development of integrated rtiI software, which can directly be integrated into imaging equipment (MRI or CT scanner) which facilitates the automation of medical image analysis. Other advances include smartphone technology integration in AI in medical imaging in which front-line health workers could non-invasively screen for various conditions by leveraging a smartphone.
- AI in medical imaging has drawn the attention of several radiologists worldwide. It gives faster and more accurate results and reduces diagnostic errors at reduced costs compared to traditional medical imaging methods. Thus, radiologists believe that AI in medical imaging may bring an enormous opportunity for its increasing implementation in the upcoming years.
- In recent years, many large established companies, such as GE Healthcare and Siemens Healthineers, have enabled themselves to grow the AI in the medical imaging market by making huge investments for increasing partnerships and acquisitions. Other large healthcare-related or software companies not previously invested in health care, such as Thermo Fisher Scientific and Paraxel, have started making huge investments in the market.
Vendor's Activity in AI-Based Medical Imaging Market
Siemens Healthineers, General Electric (GE) Company, Koninklijke Philips, and IBM Watson Health are the major players in the global AI in the medical imaging market. International players focus on developing innovative products with advanced technologies and expanding their product portfolio to remain competitive. They are continuously investing extensively in R&D to expand their product portfolio. Manufacturers such as GE Healthcare constantly focus on introducing new products with innovative technology platforms opening the platform (Edison Developer Program) for other companies offering artificial intelligence technologies to scale and deploy their developed applications across GE Healthcare's customer base.
Many major players are engaged in strategic acquisitions and partnerships that continue to be a competitive strategy for the key players, thus helping them grow inorganically. Innovative product approvals coupled with R&D activities are also helping the vendors to expand their presence, enhance growth, and sustain their position in the global market. In 2021, more than 30 countries approved AI in medical imaging technologies that are FDA and CE approved.
There is increasing funding and investments by public and private entities, including large companies, which is also one of the major driving factors of AI in the medical imaging market. For instance, more than 20 start-ups from various regions have received funds to develop AI-based medical imaging technologies.
GEOGRAPHY INSIGHTS
- North America holds a dominant position in artificial intelligence in the medical imaging market. High adoption of advanced technologies is the primary factor for its larger industry share. In addition, the strong presence of the key players in the region is also a contributor to North America for holding a high market share.
- Europe is the second-largest market for AI-based medical imaging. The presence of prominent market players and high healthcare spending are the primary factors for the significant market share in this region. The industry in Europe is mainly driven by the increasing collaborative research with extensive funding from the government. Increasing funding and investments are also driving the AI-based medical imaging market in the region.
- The adoption rate of advanced artificial intelligence technologies in the medical imaging sector is still emerging in the Asia-pacific region. In recent years, there has been a noticeable investment and funding made by government and corporations and increasing collaborations and partnerships among the companies, research centers, and institutes. Due to these factors, the industry is growing exponentially in this region.
- Lack of awareness of the importance of artificial intelligence in medical imaging, radiologists' job insecurity, a lack of sufficient IT infrastructure, a lack of proper training and knowledge among radiologists, concerns about data security, and a shortage of skilled professionals are all factors contributing to the industry's slow growth in Latin America, the Middle East, and Africa.
- Among all the regions, APAC could witness the highest growth over the forecast period, with a CAGR of 51.06% in the global industry. The increasing prevalence of chronic diseases and diagnostic errors has opened enormous opportunities for APAC medical imaging AI market growth.
Segmentation by Geography
- North America
o US
o Canada
- Europe
o Germany
o UK
o France
o Italy
o Spain
- APAC
o Japan
o China
o India
o Australia
o South Korea
- Latin America
o Brazil
o Mexico
o Argentina
- Middle East And Africa
o Turkey
o Saudi Arabia
o UAE
o South Africa
SEGMENTATION ANALYSIS
Hospitals are purchasing the artificial intelligence medical software suits as a complete package for the usage or taking up one program at a time which is used the most in the industry. The diagnostic imaging center's significant revenue generation is through imaging procedures, and they are primarily involved in implementing advanced products, which will attract customers. For instance, AI in medical imaging, along with clinical data, is helping physicians to predict heart attacks in patients accurately.
Neurology has accounted for the dominating share in the industry. The majority of the initial artificial intelligence product development focuses on downstream processing. This Downstream processing majorly includes artificial intelligence for segmentation, detecting anatomical structures, and quantifying a range of pathologies. Conditions like intracranial hemorrhage, ischemic stroke, primary brain tumors, cerebral metastases, and abnormal white matter signal intensities, which were unmet needs in the industry, has become commercially available solution within the radiology industry.
AI in medical imaging, especially cardiovascular magnetic resonance (CMR), is revolutionized by providing deep learning solutions, especially for image acquisitions, reconstructions, and analysis, which helps in supporting clinical decision-making. CMR is an established tool for routine clinical decision-making, including diagnosis, follow-up, real-time procedures, and pre-procedure planning.
Deep learning methods have enabled more tremendous success in medical image analysis. They have helped high accuracy, efficiency, stability, and scalability. Artificial intelligence tools have become assistive tools in medicine with benefits like error reduction, accuracy, fast computing, and better diagnostics. Natural language processing, Computer Vision, and Context-Aware Computing technologies are also used to create new analysis methods for medical imaging products.
In 2021, Philips showcased its new AI-enabled CT imaging portfolio. Their new CT 5100 with smart workflow application applies artificial intelligence at every step of CT image processing.
Siemens Healthineers's AI-Rad companion chest CT detects and highlights lung nodules. The tumor burden is automatically calculated.
In addition, AI-Rad companion chest X-Ray played a significant role in patient management during the COVID-19 pandemic. The artificial intelligence-Rad companion file automatically processes upright chest X-ray images, pneumothorax, nodule detection, etc. This indicates the consolidations and atelectasis. This indicates the sign of pneumonia caused by the COVID-19 virus.
Artificial intelligence in CT scans and MRI dominated the industry, as much medical imaging using artificial intelligence tools falls into these modality categories. However, artificial intelligence in ultrasound and detecting mammography is largely adopted in the industry.
Segmentation by Technology
- Deep Learning
- NIP
- Others
Segmentation by Application
- Neurology
- Respiratory & Pulmonary
- Cardiology
- Breast Screening
- Orthopedic
- Others
Segmentation by Modalities
- CT
- MRI
- X-RAY
- Ultrasound
- Nuclear Imaging
Segmentation by End-User
- Hospitals
- Diagnostic Imaging Centers
- Others
Key Vendors
- General Electric
- Siemens Healthineers
- Koninklijke Philips
- IBM Watson Health
Other Prominent Vendors
- Agfa-Gevaert Group/Agfa HealthCare
- Arterys
- Avicenna.AI
- AZmed
- Butterfly Network
- Caption Health
- CellmatiQ
- dentalXrai
- Digital Diagnostics
- EchoNous
- GLEAMER
- HeartVista
- iCAD
- Lunit
- Mediaire
- MEDO
- Nanox Imaging
- Paige AI
- Perimeter Medical Imaging AI
- Predible Health
- 1QB Information Technology
- Qure.ai
- Quantib
- QLARITY IMAGING
- Quibim
- Renalytix
- Therapixel
- Ultromics
- Viz.ai
- VUNO
KEY QUESTIONS ANSWERED
1. How Big is the Artificial Intelligence in Medical Imaging Market?
2. What is the Growth Rate of the AI in Medical Imaging Market?
3. Who are is the Key Players in the AI in Medical Imaging Market?
4. What are is the Latest Trends in the AI-Based Medical Imaging Market?
5. Which Region Is Expected to hold the largest share in the AI-Based Medical Imaging Market?
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET BY TECHNOLOGY
4.3.2 MARKET BY APPLICATION
4.3.3 MARKET BY MODALITY
4.3.4 MARKET BY END USER
4.3.5 MARKET BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 BACKGROUND
7.2 ARTIFICIAL INTELLIGENCE IN HEALTHCARE INDUSTRY
7.3 ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING
8 MARKET OPPORTUNITIES & TRENDS
8.1 TECHNOLOGICAL ADVANCES IN AI-BASED MEDICAL IMAGING
8.2 INCREASING ADOPTION OF AI-BASED MEDICAL IMAGING IN DEVELOPED COUNTRIES
8.3 GROWING INCLINATION OF RADIOLOGISTS TOWARD AI-BASED MEDICAL IMAGING
9 MARKET GROWTH ENABLERS
9.1 RISE IN NUMBER OF DIAGNOSTIC PROCEDURES
9.2 EXPANDING INVESTMENT OPPORTUNITIES IN AI-BASED MEDICAL IMAGING
9.3 RISE IN APPROVED/COMMERCIAL AI-BASED MEDICAL IMAGING PLATFORMS
9.4 DEVELOPMENTS IN AI, CLOUD-BASED, & HYBRID IMAGING SOLUTIONS
10 MARKET RESTRAINTS
10.1 LOWER ADOPTION OF AI-BASED MEDICAL IMAGING IN LMICS
10.2 LACK OF INTEGRATION AND PRACTICAL APPLICATIONS OF AI IN MEDICAL IMAGING
10.3 CONCERNS ASSOCIATED WITH DATA BREACHES IN AI-BASED MEDICAL IMAGING
11 MARKET LANDSCAPE
11.1 MARKET OVERVIEW
11.2 MARKET SIZE & FORECAST
11.2.1 INSIGHTS BY TECHNOLOGY
11.2.2 INSIGHTS BY APPLICATION
11.2.3 INSIGHTS BY MODALITY
11.2.4 INSIGHTS BY END USER
11.3 FIVE FORCES ANALYSIS
11.3.1 THREAT OF NEW ENTRANTS
11.3.2 BARGAINING POWER OF SUPPLIERS
11.3.3 BARGAINING POWER OF BUYERS
11.3.4 THREAT OF SUBSTITUTES
11.3.5 COMPETITIVE RIVALRY
12 TECHNOLOGY
12.1 MARKET SNAPSHOT & GROWTH ENGINE
12.2 MARKET OVERVIEW
12.3 DEEP LEARNING
12.3.1 MARKET OVERVIEW
12.3.2 MARKET SIZE & FORECAST
12.3.3 MARKET BY GEOGRAPHY
12.4 NLP
12.4.1 MARKET OVERVIEW
12.4.2 MARKET SIZE & FORECAST
12.4.3 MARKET BY GEOGRAPHY
12.5 OTHERS
12.5.1 MARKET OVERVIEW
12.5.2 MARKET SIZE & FORECAST
12.5.3 MARKET BY GEOGRAPHY
13 APPLICATION
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 NEUROLOGY
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 MARKET BY GEOGRAPHY
13.4 RESPIRATORY & PULMONARY
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 MARKET BY GEOGRAPHY
13.5 CARDIOLOGY
13.5.1 MARKET OVERVIEW
13.5.2 MARKET SIZE & FORECAST
13.5.3 MARKET BY GEOGRAPHY
13.6 BREAST CANCER
13.6.1 MARKET OVERVIEW
13.6.2 MARKET SIZE & FORECAST
13.6.3 MARKET BY GEOGRAPHY
13.7 ORTHOPEDIC
13.7.1 MARKET OVERVIEW
13.7.2 MARKET SIZE & FORECAST
13.7.3 MARKET BY GEOGRAPHY
13.8 OTHERS
13.8.1 MARKET OVERVIEW
13.8.2 MARKET SIZE & FORECAST
13.8.3 MARKET BY GEOGRAPHY
14 MODALITY
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 CT
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 MARKET BY GEOGRAPHY
14.4 MRI
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 MARKET BY GEOGRAPHY
14.5 X-RAY
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.5.3 MARKET BY GEOGRAPHY
14.6 ULTRASOUND
14.6.1 MARKET OVERVIEW
14.6.2 MARKET SIZE & FORECAST
14.6.3 MARKET BY GEOGRAPHY
14.7 NUCLEAR IMAGING
14.7.1 MARKET OVERVIEW
14.7.2 MARKET SIZE & FORECAST
14.7.3 MARKET BY GEOGRAPHY
15 END USER
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 HOSPITALS
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.3.3 MARKET BY GEOGRAPHY
15.4 DIAGNOSTIC IMAGING CENTERS
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.4.3 MARKET BY GEOGRAPHY
15.5 OTHERS
15.5.1 MARKET OVERVIEW
15.5.2 MARKET SIZE & FORECAST
15.5.3 MARKET BY GEOGRAPHY
16 GEOGRAPHY
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 GEOGRAPHIC OVERVIEW
17 NORTH AMERICA
17.1 MARKET OVERVIEW
17.2 MARKET SIZE & FORECAST
17.3 NORTH AMERICA: TECHNOLOGY SEGMENTATION
17.4 NORTH AMERICA: APPLICATION SEGMENTATION
17.5 NORTH AMERICA: MODALITY SEGMENTATION
17.6 NORTH AMERICA: END-USER SEGMENTATION
17.7 KEY COUNTRIES
17.7.1 US: MARKET SIZE & FORECAST
17.7.2 CANADA MARKET SIZE & FORECAST
18 EUROPE
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 EUROPE: TECHNOLOGY SEGMENTATION
18.4 EUROPE: APPLICATION SEGMENTATION
18.5 EUROPE: MODALITY SEGMENTATION
18.6 EUROPE: END-USER SEGMENTATION
18.7 KEY COUNTRIES
18.7.1 GERMANY: MARKET SIZE & FORECAST
18.7.2 UK: MARKET SIZE & FORECAST
18.7.3 FRANCE: MARKET SIZE & FORECAST
18.7.4 ITALY: MARKET SIZE & FORECAST
18.7.5 SPAIN: MARKET SIZE & FORECAST
19 APAC
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.3 APAC: TECHNOLOGY SEGMENTATION
19.4 APAC: APPLICATION SEGMENTATION
19.5 APAC: MODALITY SEGMENTATION
19.6 APAC: END-USER SEGMENTATION
19.7 KEY COUNTRIES
19.7.1 CHINA: MARKET SIZE & FORECAST
19.7.2 INDIA: MARKET SIZE & FORECAST
19.7.3 JAPAN: MARKET SIZE & FORECAST
19.7.4 AUSTRALIA: MARKET SIZE & FORECAST
19.7.5 SOUTH KOREA: MARKET SIZE & FORECAST
20 LATIN AMERICA
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.3 LATIN AMERICA: TECHNOLOGY SEGMENTATION
20.4 LATIN AMERICA: APPLICATION SEGMENTATION
20.5 LATIN AMERICA: MODALITIES SEGMENTATION
20.6 LATIN AMERICA: END-USER SEGMENTATION
20.7 KEY COUNTRIES
20.7.1 BRAZIL: MARKET SIZE & FORECAST
20.7.2 MEXICO: MARKET SIZE & FORECAST
20.7.3 ARGENTINA: MARKET SIZE & FORECAST
21 MIDDLE EAST & AFRICA
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.3 MIDDLE EAST & AFRICA: TECHNOLOGY SEGMENTATION
21.4 MIDDLE EAST & AFRICA: APPLICATION SEGMENTATION
21.5 MIDDLE EAST & AFRICA: MODALITIES SEGMENTATION
21.6 MIDDLE EAST & AFRICA: END-USER SEGMENTATION
21.7 KEY COUNTRIES
21.7.1 TURKEY: MARKET SIZE & FORECAST
21.7.2 SAUDI ARABIA: MARKET SIZE & FORECAST
21.7.3 UAE: MARKET SIZE & FORECAST
21.7.4 SOUTH AFRICA: MARKET SIZE & FORECAST
22 COMPETITIVE LANDSCAPE
22.1 COMPETITION OVERVIEW
22.2 MARKET SHARE ANALYSIS
22.2.1 GENERAL ELECTRIC
22.2.2 SIEMENS HEALTHINEERS
22.2.3 KONINKLIJKE PHILIPS
22.2.4 IBM WATSON HEALTH
23 KEY COMPANY PROFILES
23.1 GENERAL ELECTRIC
23.1.1 BUSINESS OVERVIEW
23.1.2 PRODUCT OFFERINGS
23.1.3 KEY STRATEGIES
23.1.4 KEY STRENGTHS
23.1.5 KEY OPPORTUNITIES
23.2 SIEMENS HEALTHINEERS
23.2.1 BUSINESS OVERVIEW
23.2.2 PRODUCT OFFERINGS
23.2.3 KEY STRATEGIES
23.2.4 KEY STRENGTHS
23.2.5 KEY OPPORTUNITIES
23.3 KONINKLIJKE PHILIPS
23.3.1 BUSINESS OVERVIEW
23.3.2 PRODUCT OFFERINGS
23.3.3 KEY STRATEGIES
23.3.4 KEY STRENGTHS
23.3.5 KEY OPPORTUNITIES
23.4 IBM WATSON HEALTH
23.4.1 BUSINESS OVERVIEW
23.4.2 PRODUCT OFFERINGS
23.4.3 KEY STRATEGIES
23.4.4 KEY STRENGTHS
23.4.5 KEY OPPORTUNITIES
24 OTHER PROMINENT VENDORS
24.1 AGFA-GEVAERT GROUP
24.1.1 BUSINESS OVERVIEW
24.1.2 PRODUCT OFFERINGS
24.2 ARTERYS
24.2.1 BUSINESS OVERVIEW
24.2.2 PRODUCT OFFERINGS
24.3 AVICENNA.AI
24.3.1 BUSINESS OVERVIEW
24.3.2 PRODUCT OFFERINGS
24.4 AZMED
24.4.1 BUSINESS OVERVIEW
24.4.2 PRODUCT OFFERINGS
24.5 BUTTERFLY NETWORK
24.5.1 BUSINESS OVERVIEW
24.5.2 PRODUCT OFFERINGS
24.6 CAPTION HEALTH
24.6.1 BUSINESS OVERVIEW
24.6.2 PRODUCT OFFERINGS
24.7 CELLMATIQ
24.7.1 BUSINESS OVERVIEW
24.7.2 PRODUCT OFFERINGS
24.8 DENTALXRAI
24.8.1 BUSINESS OVERVIEW
24.8.2 PRODUCT OFFERINGS
24.9 DIGITAL DIAGNOSTICS
24.9.1 BUSINESS OVERVIEW
24.9.2 PRODUCT OFFERINGS
24.10 ECHONOUS
24.10.1 BUSINESS OVERVIEW
24.10.2 PRODUCT OFFERINGS
24.11 GLEAMER
24.11.1 BUSINESS OVERVIEW
24.11.2 PRODUCT OFFERINGS
24.12 HEARTVISTA
24.12.1 BUSINESS OVERVIEW
24.12.2 PRODUCT OFFERINGS
24.13 ICAD
24.13.1 BUSINESS OVERVIEW
24.13.2 PRODUCT OFFERINGS
24.14 LUNIT
24.14.1 BUSINESS OVERVIEW
24.14.2 PRODUCT OFFERINGS
24.15 MEDIAIRE
24.15.1 BUSINESS OVERVIEW
24.15.2 PRODUCT OFFERINGS
24.16 MEDO
24.16.1 BUSINESS OVERVIEW
24.16.2 PRODUCT OFFERINGS
24.17 NANOX IMAGING
24.17.1 BUSINESS OVERVIEW
24.17.2 PRODUCT OFFERINGS
24.18 PAIGE AI
24.18.1 BUSINESS OVERVIEW
24.18.2 PRODUCT OFFERINGS
24.19 PERIMETER MEDICAL IMAGING AI
24.19.1 BUSINESS OVERVIEW
24.19.2 PRODUCT OFFERINGS
24.20 PREDIBLE HEALTH
24.20.1 BUSINESS OVERVIEW
24.20.2 PRODUCT OFFERINGS
24.21 1QB INFORMATION TECHNOLOGIES
24.21.1 BUSINESS OVERVIEW
24.21.2 PRODUCT OFFERINGS
24.22 QURI.AI
24.22.1 BUSINESS OVERVIEW
24.22.2 PRODUCT OFFERINGS
24.23 QUANTIB
24.23.1 BUSINESS OVERVIEW
24.23.2 PRODUCT OFFERINGS
24.24 QLARITY IMAGING
24.24.1 BUSINESS OVERVIEW
24.24.2 PRODUCT OFFERINGS
24.25 QUIBIM
24.25.1 BUSINESS OVERVIEW
24.25.2 PRODUCT OFFERINGS
24.26 RENALYTIX
24.26.1 BUSINESS OVERVIEW
24.26.2 PRODUCT OFFERINGS
24.27 THERAPIXEL
24.27.1 BUSINESS OVERVIEW
24.27.2 PRODUCT OFFERINGS
24.28 ULTROMICS
24.28.1 BUSINESS OVERVIEW
24.28.2 PRODUCT OFFERINGS
24.29 VIZ.AI
24.29.1 BUSINESS OVERVIEW
24.29.2 PRODUCT OFFERINGS
24.30 VUNO
24.30.1 BUSINESS OVERVIEW
24.30.2 PRODUCT OFFERINGS
25 REPORT SUMMARY
25.1 KEY TAKEAWAYS
25.2 STRATEGIC RECOMMENDATIONS
26 QUANTITATIVE SUMMARY
26.1 MARKET BY GEOGRAPHY
26.2 MARKET BY TECHNOLOGY
26.3 MARKET BY APPLICATION
26.4 MARKET BY MODALITY
26.5 MARKET BY END USER
26.6 NORTH AMERICA BY TECHNOLOGY
26.7 NORTH AMERICA BY APPLICATION
26.8 NORTH AMERICA BY MODALITY
26.9 NORTH AMERICA BY END USER
26.10 EUROPE BY TECHNOLOGY
26.11 EUROPE BY APPLICATION
26.12 EUROPE BY MODALITY
26.13 EUROPE BY END USER
26.14 APAC BY TECHNOLOGY
26.15 APAC BY APPLICATION
26.16 APAC BY MODALITY
26.17 APAC BY END USER
26.18 LATIN AMERICA BY TECHNOLOGY
26.19 LATIN AMERICA BY APPLICATION
26.20 LATIN AMERICA BY MODALITY
26.21 LATIN AMERICA BY END USER
26.22 MIDDLE EAST AND AFRICA BY TECHNOLOGY
26.23 MIDDLE EAST AND AFRICA BY APPLICATION
26.24 MIDDLE EAST AND AFRICA BY MODALITY
26.25 MIDDLE EAST AND AFRICA BY END USER
27 APPENDIX
27.1 ABBREVIATIONS
LIST OF EXHIBITS
EXHIBIT 1 SEGMENTATION OF GLOBAL AI-BASED MEDICAL IMAGING MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2022
EXHIBIT 3 SECTORS CONTRIBUTING TO DEVELOPMENT OF HEALTHCARE IT
EXHIBIT 4 SCOPE OF AI IN MEDICAL IMAGING
EXHIBIT 5 IMPACT OF TECHNOLOGICAL ADVANCES IN AI-BASED MEDICAL IMAGING
EXHIBIT 6 IMPACT OF INCREASING ADOPTION OF AI-BASED MEDICAL IMAGING IN DEVELOPED COUNTRIES
EXHIBIT 7 PERCENTAGE OF IMAGING CENTERS AND HOSPITALS IMPLEMENTING AI-BASED MEDICAL IMAGING DEVICES IN US 2019
EXHIBIT 8 IMPACT OF GROWING INCLINATION OF RADIOLOGISTS TOWARD AI-BASED MEDICAL IMAGING
EXHIBIT 9 IMPACT OF RISE IN NUMBER OF DIAGNOSTIC PROCEDURES
EXHIBIT 10 GROWTH IN IMAGING ACTIVITY 2014/15 & 2018/19 (%)
EXHIBIT 11 DIAGNOSTIC PROCEDURES/TECHNIQUES USED IN AI STUDIES
EXHIBIT 12 IMPACT OF EXPANDING INVESTMENT OPPORTUNITIES IN AI-BASED MEDICAL IMAGING
EXHIBIT 13 IMPACT OF RISE IN APPROVED/COMMERCIAL AI-BASED MEDICAL IMAGING PLATFORMS
EXHIBIT 14 IMPACT OF DEVELOPMENTS IN AI, CLOUD-BASED, & HYBRID IMAGING SOLUTIONS
EXHIBIT 15 IMPACT OF LOWER ADOPTION OF AI-BASED MEDICAL IMAGING IN LMICS
EXHIBIT 16 IMPACT OF LACK OF INTEGRATION AND PRACTICAL APPLICATIONS OF AI IN MEDICAL IMAGING
EXHIBIT 17 IMPACT OF CONCERNS ASSOCIATED WITH DATA BREACHES IN AI-BASED MEDICAL IMAGING
EXHIBIT 18 GLOBAL AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
EXHIBIT 19 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY 2021 & 2027 (%)
EXHIBIT 20 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY APPLICATION 2021 & 2027 (%)
EXHIBIT 21 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY MODALITY 2021 & 2027 (%)
EXHIBIT 22 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY END-USER 2021 & 2027 (%)
EXHIBIT 23 FIVE FORCES ANALYSIS 2021
EXHIBIT 24 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
EXHIBIT 25 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY
EXHIBIT 26 GLOBAL AI-BASED MEDICAL IMAGING BY TECHNOLOGY: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 27 GLOBAL AI-BASED MEDICAL IMAGING BY TECHNOLOGY: ABSOLUTE GROWTH (%)
EXHIBIT 28 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY DEEP LEARNING - INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 29 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY DEEP LEARNING 2021-2027 ($ MILLION)
EXHIBIT 30 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY DEEP LEARNING: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 31 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY NLP 2021-2027 ($ MILLION)
EXHIBIT 32 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY NLP: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 33 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY NLP: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 34 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY OTHER TECHNOLOGIES: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 35 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY OTHER TECHNOLOGIES 2021-2027 ($ MILLION)
EXHIBIT 36 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY OTHER TECHNOLOGIES: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 37 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 38 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY APPLICATION
EXHIBIT 39 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY APPLICATION: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 40 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY APPLICATION: ABSOLUTE GROWTH (%)
EXHIBIT 41 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY NEUROLOGY: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 42 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY NEUROLOGY 2021-2027 ($ MILLION)
EXHIBIT 43 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY NEUROLOGY: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 44 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY RESPIRATORY & PULMONARY 2021-2027 ($ MILLION)
EXHIBIT 45 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY RESPIRATORY AND PULMONARY: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 46 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY RESPIRATORY & PULMONARY: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 47 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY CARDIOLOGY: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 48 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY CARDIOLOGY 2021-2027 ($ MILLION)
EXHIBIT 49 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY CARDIOLOGY: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 50 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY BREAST SCREENING: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 51 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY BREAST SCREENING 2021-2027 ($ MILLION)
EXHIBIT 52 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY BREAST SCREENING: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 53 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY ORTHOPEDIC: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 54 MOST STUDIED ORTHOPEDIC AREAS FOR AI-BASED IMAGE INTERPRETATION (%)
EXHIBIT 55 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY ORTHOPEDIC 2021-2027 ($ MILLION)
EXHIBIT 56 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY ORTHOPEDIC: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 57 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY OTHER APPLICATIONS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 58 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY OTHER APPLICATIONS 2021-2027 ($ MILLION)
EXHIBIT 59 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY OTHER APPLICATIONS: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 60 INCREMENTAL GROWTH BY MODALITY 2021 & 2027
EXHIBIT 61 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY MODALITY
EXHIBIT 62 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY MODALITY: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 63 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY MODALITY: ABSOLUTE GROWTH (%)
EXHIBIT 64 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY CT 2021-2027 ($ MILLION)
EXHIBIT 65 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY CT: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 66 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY CT: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 67 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY MRI: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 68 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY MRI 2021-2027 ($ MILLION)
EXHIBIT 69 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY MRI: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 70 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY X-RAY: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 71 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY X-RAY 2021-2027 ($ MILLION)
EXHIBIT 72 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY X-RAY: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 73 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY ULTRASOUND: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 74 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY ULTRASOUND 2021-2027 ($ MILLION)
EXHIBIT 75 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY ULTRASOUND: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 76 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY NUCLEAR IMAGING 2021-2027 ($ MILLION)
EXHIBIT 77 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY NUCLEAR IMAGING: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 78 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY NUCLEAR IMAGING: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 79 INCREMENTAL GROWTH BY END USER 2021 & 2027
EXHIBIT 80 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY END USER
EXHIBIT 81 GLOBAL AI-BASED MEDICAL IMAGING BY END USER: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 82 GLOBAL AI-BASED MEDICAL IMAGING BY END USER: ABSOLUTE GROWTH (%)
EXHIBIT 83 PERCENTAGE OF ANNUAL EXAMINATIONS PER RADIOLOGY DEPARTMENT IN US
EXHIBIT 84 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY HOSPITALS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 85 DIAGNOSTIC ERRORS IN DIFFERENT AREAS IN FINLAND (%)
EXHIBIT 86 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY HOSPITALS 2021-2027 ($ MILLION)
EXHIBIT 87 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY HOSPITALS: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 88 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY DIAGNOSTIC IMAGING CENTER: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 89 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY DIAGNOSTIC IMAGING CENTERS 2021-2027 ($ MILLION)
EXHIBIT 90 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY DIAGNOSTIC IMAGING CENTERS: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 91 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY OTHER END USERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 92 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY OTHER END USERS 2021-2027 ($ MILLION)
EXHIBIT 93 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY OTHER END USERS: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 94 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 95 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY GEOGRAPHY
EXHIBIT 96 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY GEOGRAPHY: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 97 GLOBAL AI-BASED MEDICAL IMAGING BY GEOGRAPHY: ABSOLUTE GROWTH (%)
EXHIBIT 98 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 99 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET: KEY COUNTRIES 2021 ($ MILLION)
EXHIBIT 100 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
EXHIBIT 101 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
EXHIBIT 102 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 103 INCREMENTAL GROWTH BY MODALITY 2021 & 2027
EXHIBIT 104 INCREMENTAL GROWTH BY END USER 2021 & 2027
EXHIBIT 105 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027
EXHIBIT 106 US AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
EXHIBIT 107 CANADA AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
EXHIBIT 108 EUROPE AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
EXHIBIT 109 EUROPE AI-BASED MEDICAL IMAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 110 EUROPE AI-BASED MEDICAL IMAGING MARKET: KEY COUNTRIES 2021($ MILLION)
EXHIBIT 111 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
EXHIBIT 112 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 113 INCREMENTAL GROWTH BY MODALITY 2021 & 2027
EXHIBIT 114 INCREMENTAL GROWTH BY END USER 2021 & 2027
EXHIBIT 115 INCREMENTAL GROWTH IN EUROPE 2021 & 2027
EXHIBIT 116 GERMANY AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
EXHIBIT 117 UK AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
EXHIBIT 118 FRANCE AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
EXHIBIT 119 MEDICAL IMAGING ACTIVITIES IN ITALY (%)
EXHIBIT 120 ITALY AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
EXHIBIT 121 SPAIN AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
EXHIBIT 122 APAC AI-BASED MEDICAL IMAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 123 APAC AI-BASED MEDICAL IMAGING MARKET: KEY COUNTRIES 2021 ($ MILLION)
EXHIBIT 124 APAC AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
EXHIBIT 125 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
EXHIBIT 126 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 127 INCREMENTAL GROWTH BY MODALITY 2021 & 2027
EXHIBIT 128 INCREMENTAL GROWTH BY END USER 2021 & 2027
EXHIBIT 129 INCREMENTAL GROWTH IN APAC 2021 & 2027
EXHIBIT 130 CHINA AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
EXHIBIT 131 AI-BASED MEDICAL IMAGING MARKET IN INDIA 2021-2027 ($ MILLION)
EXHIBIT 132 JAPAN AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
EXHIBIT 133 AUSTRALIA AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
EXHIBIT 134 AI-BASED MEDICAL IMAGING MARKET IN SOUTH KOREA 2021-2027 ($ MILLION)
EXHIBIT 135 LATIN AMERICA AI-BASED MEDICAL IMAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 136 LATIN AMERICA AI-BASED MEDICAL IMAGING MARKET: KEY COUNTRIES 2021 ($ MILLION)
EXHIBIT 137 LATIN AMERICA AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
EXHIBIT 138 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
EXHIBIT 139 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 140 INCREMENTAL GROWTH BY MODALITIES 2021 & 2027
EXHIBIT 141 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 142 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027
EXHIBIT 143 BRAZIL AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
EXHIBIT 144 MEXICO AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
EXHIBIT 145 ARGENTINA AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
EXHIBIT 146 MIDDLE EAST & AFRICA AI-BASED MEDICAL IMAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 147 MIDDLE EAST & AFRICA AI-BASED MEDICAL IMAGING MARKET: KEY COUNTRIES 2021 ($ MILLION)
EXHIBIT 148 MIDDLE EAST & AFRICA AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
EXHIBIT 149 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
EXHIBIT 150 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 151 INCREMENTAL GROWTH BY MODALITIES 2021 & 2027
EXHIBIT 152 INCREMENTAL GROWTH BY END USER 2021 & 2027
EXHIBIT 153 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027
EXHIBIT 154 AI-BASED MEDICAL IMAGING MARKET IN TURKEY 2021-2027 ($ MILLION)
EXHIBIT 155 SAUDI ARABIA AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
EXHIBIT 156 UAE AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
EXHIBIT 157 SOUTH AFRICA AI-BASED MEDICAL IMAGING MARKET 2021-2027 ($ MILLION)
EXHIBIT 158 PURE & DIVERSIFIED COMPANIES IN GLOBAL AI-BASED MEDICAL IMAGING MARKET
EXHIBIT 159 GLOBAL AI-BASED MEDICAL IMAGING MARKET: MARKET DOMINANCE ANALYSIS
EXHIBIT 160 VENDORS IN GLOBAL AI-BASED MEDICAL IMAGING MARKET: CAPABILITIES & EXPERTISE ASSESSMENT
EXHIBIT 161 GENERAL ELECTRIC: TOTAL REVENUE 2019-2021 ($ MILLION)
EXHIBIT 162 GENERAL ELECTRIC: TOTAL REVENUE BY HEALTHCARE SEGMENT 2019-2021 ($ MILLION)
EXHIBIT 163 GENERAL ELECTRIC: R&D EXPENDITURE IN HEALTHCARE SEGMENT 2019-2021 ($ MILLION)
EXHIBIT 164 SIEMENS HEALTHINEERS: TOTAL REVENUE 2019-2021 ($ MILLION)
EXHIBIT 165 SIEMENS HEALTHINEERS: TOTAL REVENUE BY IMAGING SEGMENT 2019-2021 ($ MILLION)
EXHIBIT 166 KONINKLIJKE PHILIPS: REVENUE BY DIAGNOSIS AND TREATMENT BUSINESS 2019-2021 ($ MILLION)
EXHIBIT 167 KONINKLIJKE PHILIPS: R&D EXPENDITURE IN DIAGNOSIS AND TREATMENT BUSINESS SEGMENT 2019-2021 ($ MILLION)
EXHIBIT 168 IBM: TOTAL REVENUE 2018-2020 ($ MILLION)
EXHIBIT 169 IBM: TOTAL R&D EXPENDITURE ($ MILLION)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015?2021
TABLE 3 START-UPS INVOLVED IN DEVELOPMENT OF AI-BASED MEDICAL IMAGING
TABLE 4 LIST OF FDA-APPROVED AI-BASED MEDICAL IMAGING PLATFORMS
TABLE 5 GENERAL ELECTRIC: MAJOR PRODUCT OFFERINGS
TABLE 6 SIEMENS HEALTHINEERS: MAJOR PRODUCT OFFERINGS
TABLE 7 KONINKLIJKE PHILIPS: MAJOR PRODUCT OFFERINGS
TABLE 8 IBM: MAJOR PRODUCT OFFERINGS
TABLE 9 AGFA-GEVAERT GROUP: MAJOR PRODUCT OFFERINGS
TABLE 10 ARTERYS: MAJOR PRODUCT OFFERINGS
TABLE 11 AVICENNA.AI: MAJOR PRODUCT OFFERINGS
TABLE 12 AZMED: MAJOR PRODUCT OFFERINGS
TABLE 13 BUTTERFLY NETWORK: MAJOR PRODUCT OFFERINGS
TABLE 14 CAPTION HEALTH: MAJOR PRODUCT OFFERINGS
TABLE 15 CELLMATIQ: MAJOR PRODUCT OFFERINGS
TABLE 16 DENTALXRAI: MAJOR PRODUCT OFFERINGS
TABLE 17 DIGITAL DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
TABLE 18 ECHONOUS: MAJOR PRODUCT OFFERINGS
TABLE 19 GLEAMER: MAJOR PRODUCT OFFERINGS
TABLE 20 HEARTVISTA: MAJOR PRODUCT OFFERINGS
TABLE 21 ICAD: MAJOR PRODUCT OFFERINGS
TABLE 22 LUNIT: MAJOR PRODUCT OFFERINGS
TABLE 23 MEDIAIRE: MAJOR PRODUCT OFFERINGS
TABLE 24 MEDO: MAJOR PRODUCT OFFERINGS
TABLE 25 NANOX IMAGING: MAJOR PRODUCT OFFERINGS
TABLE 26 PAIGE AI: MAJOR PRODUCT OFFERINGS
TABLE 27 PERIMETER MEDICAL IMAGING AI: MAJOR PRODUCT OFFERINGS
TABLE 28 PREDIBLE HEALTH: MAJOR PRODUCT OFFERINGS
TABLE 29 1QB INFORMATION TECHNOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 30 QURE.AI: MAJOR PRODUCT OFFERINGS
TABLE 31 QUANTIB: MAJOR PRODUCT OFFERINGS
TABLE 32 QLARITY IMAGING: MAJOR PRODUCT OFFERINGS
TABLE 33 QUIBIM: MAJOR PRODUCT OFFERINGS
TABLE 34 RENALYTIX: MAJOR PRODUCT OFFERINGS
TABLE 35 THERAPIXEL: MAJOR PRODUCT OFFERINGS
TABLE 36 ULTROMICS: MAJOR PRODUCT OFFERINGS
TABLE 37 VIZ.AI: MAJOR PRODUCT OFFERINGS
TABLE 38 VUNO: MAJOR PRODUCT OFFERINGS
TABLE 39 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
TABLE 40 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY GEOGRAPHY 2021-2027 (%)
TABLE 41 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY 2021-2027 ($ MILLION)
TABLE 42 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY 2021-2027 (%)
TABLE 43 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY APPLICATION 2021-2027 ($ MILLION)
TABLE 44 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY APPLICATION 2021-2027 (%)
TABLE 45 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY MODALITY 2021-2027 ($ MILLION)
TABLE 46 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY MODALITY 2021-2027 (%)
TABLE 47 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY END USER 2021-2027 ($ MILLION)
TABLE 48 GLOBAL AI-BASED MEDICAL IMAGING MARKET BY END USER 2021-2027 (%)
TABLE 49 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY 2021-2027 ($ MILLION)
TABLE 50 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY 2021-2027 (%)
TABLE 51 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET BY APPLICATION 2021-2027 ($ MILLION)
TABLE 52 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET BY APPLICATION 2021-2027 (%)
TABLE 53 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET BY MODALITY 2021-2027 ($ MILLION)
TABLE 54 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET BY MODALITY 2021-2027 (%)
TABLE 55 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET BY END USER 2021-2027 ($ MILLION)
TABLE 56 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET BY END USER 2021-2027 (%)
TABLE 57 EUROPE AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY 2021-2027 ($ MILLION)
TABLE 58 EUROPE AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY 2021-2027 (%)
TABLE 59 EUROPE AI-BASED MEDICAL IMAGING MARKET BY APPLICATION 2021-2027 ($ MILLION)
TABLE 60 EUROPE AI-BASED MEDICAL IMAGING MARKET BY APPLICATION 2021-2027 (%)
TABLE 61 EUROPE AI-BASED MEDICAL IMAGING MARKET BY MODALITY 2021-2027 ($ MILLION)
TABLE 62 EUROPE AI-BASED MEDICAL IMAGING MARKET BY MODALITY 2021-2027 (%)
TABLE 63 EUROPE AI-BASED MEDICAL IMAGING MARKET BY END USER 2021-2027 ($ MILLION)
TABLE 64 EUROPE AI-BASED MEDICAL IMAGING MARKET BY END USER 2021-2027 (%)
TABLE 65 APAC AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY 2021-2027 ($ MILLION)
TABLE 66 APAC AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY 2021-2027 (%)
TABLE 67 APAC AI-BASED MEDICAL IMAGING MARKET BY APPLICATION 2021-2027 ($ MILLION)
TABLE 68 APAC AI-BASED MEDICAL IMAGING MARKET BY APPLICATION 2021-2027 (%)
TABLE 69 APAC AI-BASED MEDICAL IMAGING MARKET BY MODALITY 2021-2027 ($ MILLION)
TABLE 70 APAC AI-BASED MEDICAL IMAGING MARKET BY MODALITY 2021-2027 (%)
TABLE 71 APAC AI-BASED MEDICAL IMAGING MARKET BY END USER 2021-2027 ($ MILLION)
TABLE 72 APAC AI-BASED MEDICAL IMAGING MARKET BY END USER 2021-2027 (%)
TABLE 73 LATIN AMERICA AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY 2021-2027 ($ MILLION)
TABLE 74 LATIN AMERICA AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY 2021-2027 (%)
TABLE 75 LATIN AMERICA AI-BASED MEDICAL IMAGING MARKET BY APPLICATION 2021-2027 ($ MILLION)
TABLE 76 LATIN AMERICA AI-BASED MEDICAL IMAGING MARKET BY APPLICATION 2021-2027 (%)
TABLE 77 LATIN AMERICA AI-BASED MEDICAL IMAGING MARKET BY MODALITY 2021-2027 ($ MILLION)
TABLE 78 LATIN AMERICA AI-BASED MEDICAL IMAGING MARKET BY MODALITY 2021-2027 (%)
TABLE 79 LATIN AMERICA AI-BASED MEDICAL IMAGING MARKET BY END USER 2021-2027 ($ MILLION)
TABLE 80 LATIN AMERICA AI-BASED MEDICAL IMAGING MARKET BY END USER 2021-2027 (%)
TABLE 81 MIDDLE EAST AND AFRICA AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY 2021-2027 ($ MILLION)
TABLE 82 MIDDLE EAST AND AFRICA AI-BASED MEDICAL IMAGING MARKET BY TECHNOLOGY 2021-2027 (%)
TABLE 83 MIDDLE EAST AND AFRICA AI-BASED MEDICAL IMAGING MARKET BY APPLICATION 2021-2027 ($ MILLION)
TABLE 84 MIDDLE EAST AND AFRICA AI-BASED MEDICAL IMAGING MARKET BY APPLICATION 2021-2027 (%)
TABLE 85 MIDDLE EAST AND AFRICA AI-BASED MEDICAL IMAGING MARKET BY MODALITY 2021-2027 ($ MILLION)
TABLE 86 MIDDLE EAST AND AFRICA AI-BASED MEDICAL IMAGING MARKET BY MODALITY 2021-2027 (%)
TABLE 87 MIDDLE EAST AND AFRICA AI-BASED MEDICAL IMAGING MARKET BY END USER 2021-2027 ($ MILLION)
TABLE 88 MIDDLE EAST AND AFRICA AI-BASED MEDICAL IMAGING MARKET BY END USER 2021-2027 (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security